Rakesh K Jain

Citado por

	Total	Desde 2020
Citas	245765	76616
Índice h	229	133
Índice i10	668	484

17000

8500

4250

12750

1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025613 960 1184 1703 1775 1781 2441 3037 3497 3800 4903 5731 6305 6973 7321 8146 9486 10620 11217 11786 11669 11989 12097 12395 12567 14741 16589 15984 14170 13336 1732

Acceso público

Ver todo

280 artículos

7 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Dan G. Duda, DMD, PhDProfessor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical SchoolDirección de correo verificada de partners.org
Lance MunnHarvard Medical SchoolDirección de correo verificada de steele.mgh.harvard.edu
Emmanuelle di TomasoHarvard, UCL, Scripps, Novartis, Syros, BayerDirección de correo verificada de bayer.com
Triantafyllos StylianopoulosAssociate Professor of Mechanical Engineering, Cancer Biophysics Lab, University of CyprusDirección de correo verificada de ucy.ac.cy
Fan YuanDepartment of Biomedical Engineering, Duke University, Durham, NC 27708Dirección de correo verificada de duke.edu
Moungi G. BawendiMassachusetts Institute of TechnologyDirección de correo verificada de mit.edu
A. Gregory SorensenDeepHealth, Inc.Dirección de correo verificada de deep.health
Peter Carmeliethoogleraar, Universiteit van Leuven, VIBDirección de correo verificada de kuleuven.vib.be
David Alan BerkSenior Lecturer in Pharmacokinetics & Drug DeliveryDirección de correo verificada de alumni.duke.edu
John MartinMateria TherapeuticsDirección de correo verificada de mit.edu
Vikash P. ChauhanLSRF Postdoctoral Fellow, MITDirección de correo verificada de mit.edu
Walid KamounTakedaDirección de correo verificada de takeda.com
Patrick WenProfessor of Neurology, Harvard Medical SchoolDirección de correo verificada de dfci.harvard.edu
Paolo NettiIstituto Italiano di tecnologia (IIT) and University of Naples Federico IIDirección de correo verificada de unina.it

Seguir

Rakesh K Jain

Otros nombresRakesh Jain

Massachusetts General Hospital, Harvard Medical School, Carnegie Mellon, Columbia, Delaware

Dirección de correo verificada de steele.mgh.harvard.edu - Página principal


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Angiogenesis in cancer and other diseases P Carmeliet, RK Jain nature 407 (6801), 249-257, 2000	12135	2000
Photodynamic therapy for cancer DE Dolmans, D Fukumura, RK Jain Nature reviews cancer 3 (5), 380-387, 2003	7652	2003
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy RK Jain Science 307 (5706), 58-62, 2005	6619	2005
Molecular mechanisms and clinical applications of angiogenesis P Carmeliet, RK Jain Nature 473 (7347), 298-307, 2011	6324	2011
Understanding the tumor immune microenvironment (TIME) for effective therapy M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ... Nature medicine 24 (5), 541-550, 2018	4716	2018
Delivering nanomedicine to solid tumors RK Jain, T Stylianopoulos Nature reviews Clinical oncology 7 (11), 653-664, 2010	3616	2010
Molecular regulation of vessel maturation RK Jain Nature medicine 9 (6), 685-693, 2003	3451	2003
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ... Nature 394 (6692), 485-490, 1998	3447	1998
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment SK Hobbs, WL Monsky, F Yuan, WG Roberts, L Griffith, VP Torchilin, ... Proceedings of the National Academy of Sciences 95 (8), 4607-4612, 1998	3065	1998
A framework for advancing our understanding of cancer-associated fibroblasts E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ... Nature Reviews Cancer 20 (3), 174-186, 2020	2996	2020
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy RK Jain Nature medicine 7 (9), 987-989, 2001	2741	2001
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ... Nature medicine 10 (2), 145-147, 2004	2521	2004
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size F Yuan, M Dellian, D Fukumura, M Leunig, DA Berk, VP Torchilin, RK Jain Cancer research 55 (17), 3752-3756, 1995	2333	1995
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007	2124	2007
Openings between defective endothelial cells explain tumor vessel leakiness H Hashizume, P Baluk, S Morikawa, JW McLean, G Thurston, S Roberge, ... The American journal of pathology 156 (4), 1363-1380, 2000	2118	2000
Interstitial pH and pO₂ gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation G Helmlinger, F Yuan, M Dellian, RK Jain Nature medicine 3 (2), 177-182, 1997	2047	1997
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020	1959	2020
Transport of molecules in the tumor interstitium: a review RK Jain Cancer research 47 (12), 3039-3051, 1987	1935	1987
Determinants of tumor blood flow: a review RK Jain Cancer research 48 (10), 2641-2658, 1988	1931	1988
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases P Carmeliet, RK Jain Nature reviews Drug discovery 10 (6), 417-427, 2011	1904	2011

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores